• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒介导的 mRNA 递呈的最佳递送策略。

Optimal delivery strategies for nanoparticle-mediated mRNA delivery.

机构信息

Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou 450001, China.

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.

出版信息

J Mater Chem B. 2023 Mar 8;11(10):2063-2077. doi: 10.1039/d2tb02455a.

DOI:10.1039/d2tb02455a
PMID:36794598
Abstract

Messenger RNA (mRNA) has emerged as a new and efficient agent for the treatment of various diseases. The success of lipid nanoparticle-mRNA against the novel coronavirus (SARS-CoV-2) pneumonia epidemic has proved the clinical potential of nanoparticle-mRNA formulations. However, the deficiency in the effective biological distribution, high transfection efficiency and good biosafety are still the major challenges in clinical translation of nanomedicine for mRNA delivery. To date, a variety of promising nanoparticles have been constructed and then gradually optimized to facilitate the effective biodistribution of carriers and efficient mRNA delivery. In this review, we describe the design of nanoparticles with an emphasis on lipid nanoparticles, and discuss the manipulation strategies for nanoparticle-biology (nano-bio) interactions for mRNA delivery to overcome the biological barriers and improve the delivery efficiency, because the specific nano-bio interaction of nanoparticles usually remoulds the biomedical and physiological properties of the nanoparticles especially the biodistribution, mechanism of cellular internalization and immune response. Finally, we give a perspective for the future applications of this promising technology. We believe that the regulation of nano-bio interactions would be a significant breakthrough to improve the mRNA delivery efficiency and cross biological barriers. This review may provide a new direction for the design of nanoparticle-mediated mRNA delivery systems.

摘要

信使 RNA(mRNA)已成为治疗各种疾病的新型高效药物。脂质纳米颗粒-mRNA 对新型冠状病毒(SARS-CoV-2)肺炎疫情的成功治疗证明了纳米颗粒-mRNA 制剂的临床潜力。然而,有效的生物分布、高转染效率和良好的生物安全性仍然是 mRNA 传递的纳米医学临床转化的主要挑战。迄今为止,已经构建了多种有前途的纳米颗粒,并对其进行了逐步优化,以促进载体的有效生物分布和高效 mRNA 传递。在本综述中,我们重点介绍了脂质纳米颗粒的纳米颗粒设计,并讨论了用于克服生物屏障和提高递送效率的纳米颗粒-生物学(nano-bio)相互作用的操纵策略,因为纳米颗粒的特定 nano-bio 相互作用通常会重塑纳米颗粒的生物医学和生理学特性,特别是生物分布、细胞内化机制和免疫反应。最后,我们对这项有前途的技术的未来应用提出了展望。我们相信,对 nano-bio 相互作用的调控将是提高 mRNA 传递效率和跨越生物屏障的重要突破。本综述可能为纳米颗粒介导的 mRNA 传递系统的设计提供新的方向。

相似文献

1
Optimal delivery strategies for nanoparticle-mediated mRNA delivery.纳米颗粒介导的 mRNA 递呈的最佳递送策略。
J Mater Chem B. 2023 Mar 8;11(10):2063-2077. doi: 10.1039/d2tb02455a.
2
The nano delivery systems and applications of mRNA.mRNA 的纳米递药系统与应用。
Eur J Med Chem. 2022 Jan 5;227:113910. doi: 10.1016/j.ejmech.2021.113910. Epub 2021 Oct 8.
3
Lipid nanoparticles for mRNA delivery.用于mRNA递送的脂质纳米颗粒。
Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10.
4
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.用于细胞内 mRNA 递送和基因组编辑的可生物降解脂质纳米粒子的开发。
Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20.
5
Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.用于优化基于 RNA 的经皮递送至小鼠气道的脂质纳米颗粒制剂。
Eur J Pharm Sci. 2022 Sep 1;176:106234. doi: 10.1016/j.ejps.2022.106234. Epub 2022 Jun 8.
6
Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications.微流控技术生产用于疫苗应用的载 mRNA 脂质纳米粒。
Expert Opin Drug Deliv. 2022 Oct;19(10):1381-1395. doi: 10.1080/17425247.2022.2135502. Epub 2022 Oct 20.
7
Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines.脂质纳米颗粒 mRNA 疗法在 COVID-19 疫苗之外的进展。
Nanoscale. 2024 Apr 4;16(14):6820-6836. doi: 10.1039/d4nr00019f.
8
Lipid Nanocarrier-Based mRNA Therapy: Challenges and Promise for Clinical Transformation.基于脂质纳米载体的mRNA疗法:临床转化面临的挑战与前景
Small. 2024 Jul;20(28):e2310531. doi: 10.1002/smll.202310531. Epub 2024 Jan 29.
9
Chemistry of Lipid Nanoparticles for RNA Delivery.脂质纳米颗粒的 RNA 递送化学。
Acc Chem Res. 2022 Jan 4;55(1):2-12. doi: 10.1021/acs.accounts.1c00544. Epub 2021 Dec 1.
10
Unraveling mRNA delivery bottlenecks of ineffective delivery vectors by co-transfection with effective carriers.通过与有效载体共转染来揭示无效递送载体的mRNA递送瓶颈。
Eur J Pharm Biopharm. 2024 Sep;202:114414. doi: 10.1016/j.ejpb.2024.114414. Epub 2024 Jul 14.

引用本文的文献

1
Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.针对 RNA 治疗药物靶向递送而设计的脂质纳米粒的体内复杂旅程的探索:一种基于质量设计的方法。
J Nanobiotechnology. 2024 Nov 14;22(1):710. doi: 10.1186/s12951-024-02972-w.
2
Bioinspired cellular membrane-derived vesicles for mRNA delivery.仿生细胞膜衍生囊泡用于 mRNA 递送。
Theranostics. 2024 May 19;14(8):3246-3266. doi: 10.7150/thno.93755. eCollection 2024.